Cervical and vaginal shedding of human immunodeficiency virus type 1-infected cells throughout the menstrual cycle

被引:51
作者
Mostad, SB
Jackson, S
Overbaugh, J
Reilly, M
Chohan, B
Mandaliya, K
Nyange, P
Ndinya-Achola, J
Bwayo, JJ
Kreiss, JK
机构
[1] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Med, Seattle, WA 98195 USA
[4] Univ Coll Dublin, Dept Stat, Dublin 2, Ireland
[5] Coastal Prov Gen Hosp, Mombasa, Kenya
[6] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya
关键词
D O I
10.1086/515665
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cervical and vaginal secretions from 17 women infected with human immunodeficiency virus type 1 (HIV-1) were evaluated daily through the course of one menstrual cycle for HIV-1 DNA (21-31 visits per woman). HIV-1-infected cells were detected in 207 (46%) of 450 endocervical swabs and 74 (16%) of 449 vaginal swabs. There was considerable variability in the percentage of positive swabs from each woman, ranging from 4% to 100% of endocervical swabs and from 0 to 71% of vaginal swabs. In multivariate analyses, plasma HIV-1 RNA was significantly associated with shedding of HIV-1-infected cells; each 1-unit increase in the log of plasma virus load was associated with a 5.6-fold increase in the odds of cervical shedding (95% confidence interval [CI], 2.1-14.8) and a 3.9-fold increase in the odds of vaginal shedding (95% CI, 2.1-7.2). There was no discernible pattern of genital tract shedding with phase of the menstrual cycle and no significant association with serum estradiol or progesterone levels.
引用
收藏
页码:983 / 991
页数:9
相关论文
共 31 条
[1]  
Beller FK, 1979, BIOL FLUIDS FEMALE G
[2]   DETECTION OF HIV DNA IN CERVICAL AND VAGINAL SECRETIONS - PREVALENCE AND CORRELATES AMONG WOMEN IN NAIROBI, KENYA [J].
CLEMETSON, DBA ;
MOSS, GB ;
WILLERFORD, DM ;
HENSEL, M ;
EMONYI, W ;
HOLMES, KK ;
PLUMMER, F ;
NDINYAACHOLA, J ;
ROBERTS, PL ;
HILLIER, S ;
KREISS, JK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (22) :2860-2864
[3]   Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine [J].
Collier, AC ;
Coombs, RW ;
Schoenfeld, DA ;
Bassett, RL ;
Timpone, J ;
Baruch, A ;
Jones, M ;
Facey, K ;
Whitacre, C ;
McAuliffe, VJ ;
Friedman, HM ;
Merigan, TC ;
Reichman, RC ;
Hooper, C ;
Corey, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (16) :1011-1017
[4]   PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
COOMBS, RW ;
COLLIER, AC ;
ALLAIN, JP ;
NIKORA, B ;
LEUTHER, M ;
GJERSET, GF ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1626-1631
[5]   GENETIC-RELATIONSHIPS DETERMINED BY A DNA HETERODUPLEX MOBILITY ASSAY - ANALYSIS OF HIV-1 ENV GENES [J].
DELWART, EL ;
SHPAER, EG ;
LOUWAGIE, J ;
MCCUTCHAN, FE ;
GREZ, M ;
RUBSAMENWAIGMANN, H ;
MULLINS, JI .
SCIENCE, 1993, 262 (5137) :1257-1261
[6]  
DEVINCENZI I, 1992, BRIT MED J, V304, P809
[7]   PREVALENCE OF HYDROGEN PEROXIDE-PRODUCING LACTOBACILLUS SPECIES IN NORMAL WOMEN AND WOMEN WITH BACTERIAL VAGINOSIS [J].
ESCHENBACH, DA ;
DAVICK, PR ;
WILLIAMS, BL ;
KLEBANOFF, SJ ;
YOUNGSMITH, K ;
CRITCHLOW, CM ;
HOLMES, KK .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (02) :251-256
[8]  
*EXP GROUP JOINT U, 1997, AIDS, V11
[9]  
FERIN M, 1993, MENSTRUAL CYCLE PHYS, P62
[10]   Human immunodeficiency virus in plasma and genital secretions during the menstrual cycle [J].
Goulston, C ;
Stevens, E ;
Gallo, D ;
Mullins, JI ;
Hanson, CV ;
Katzenstein, D .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04) :858-861